These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 14983619)

  • 1. Prescription drugs and medical costs: four opportunities for health plans and physicians to make a difference.
    Greczyn RJ
    N C Med J; 2003; 64(6):285-6. PubMed ID: 14983619
    [No Abstract]   [Full Text] [Related]  

  • 2. Prudent prescribing. Prescribing suggestions for physicians.
    Jordan LK; Jordan LO
    N C Med J; 1992 Nov; 53(11):585-8. PubMed ID: 1436152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduce prescription of expensive drugs without increased value].
    Furberg C
    Lakartidningen; 2003 Dec; 100(49):4113. PubMed ID: 14717079
    [No Abstract]   [Full Text] [Related]  

  • 4. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 5. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?
    Granlund D
    Soc Sci Med; 2009 Dec; 69(11):1643-50. PubMed ID: 19815322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Positive attitude to prescription of generic preparations. Report from the Genvagen-project in western Gotaland].
    Iwarson S; Carlsten A; Edward M
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1911-3. PubMed ID: 16044773
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing prescription drug costs.
    Sica JM
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keeping prescription drugs affordable.
    Arp D
    Healthplan; 2002; 43(6):12-5. PubMed ID: 12506430
    [No Abstract]   [Full Text] [Related]  

  • 9. Rising drug costs: the impact on dermatology.
    Rico MJ
    Skin Therapy Lett; 2000; 5(4):1-2,5. PubMed ID: 10785406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Out-of-pocket and total costs of fixed-dose combination antihypertensives and their components.
    Rabbani A; Alexander GC
    Am J Hypertens; 2008 May; 21(5):509-13. PubMed ID: 18437141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowering the cost of prescription drugs.
    Jindal B
    J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical regulator urges doctors to prescribe generic drugs.
    Bhaumik S
    BMJ; 2013 Jan; 346():f564. PubMed ID: 23358490
    [No Abstract]   [Full Text] [Related]  

  • 13. To cut costs, risky drug use.
    Consum Rep; 2011 Nov; 76(11):9. PubMed ID: 22022754
    [No Abstract]   [Full Text] [Related]  

  • 14. Forecasting the future.
    Tecnologica; 1999 Dec; ():1, 3-6, 14-5. PubMed ID: 10848110
    [No Abstract]   [Full Text] [Related]  

  • 15. [Do the fee-for-service and reimbursement influence medical practice?].
    Fretheim A; Håvelsrud K; Flottorp S; Oxman AD
    Tidsskr Nor Laegeforen; 2003 Mar; 123(6):795-6. PubMed ID: 12693118
    [No Abstract]   [Full Text] [Related]  

  • 16. Health plans keeping drug cost increases in check with programs that promote generics.
    Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians' opinions and experiences of the Pharmaceutical Benefits Reform.
    Andersson K; Jörgensen T; Carlsten A
    Scand J Public Health; 2006; 34(6):654-9. PubMed ID: 17132599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the impact of reference-based pricing.
    Grootendorst P; Holbrook A
    CMAJ; 1999 Aug; 161(3):273-4. PubMed ID: 10463048
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacists want to assume penalty].
    MMW Fortschr Med; 2006 May; 148(20):55. PubMed ID: 16805194
    [No Abstract]   [Full Text] [Related]  

  • 20. Study examines weapons in fight to control drug costs.
    Capitation Rates Data; 2001 Apr; 6(4):39-42. PubMed ID: 11330005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.